CytoVale

South San Francisco, United States

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

Apr 2025

Venture - Series Unknown

Top Investors

Alumni VenturesNorwestSands Capital VenturesNational Science FoundationBlackhorn Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are CytoVale's investors?

CytoVale's investors include Alumni Ventures, Norwest, Sands Capital Ventures, National Science Foundation, Blackhorn Ventures.

Where is CytoVale headquartered?

CytoVale is headquartered in South San Francisco, United States.

What does CytoVale do?

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

What stage is CytoVale at?

CytoVale is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 15, 2025.

MLA

"CytoVale — Funding & Investors." VCBacked, April 15, 2025, https://www.vcbacked.co/company/cytovale. Accessed July 1, 2026.

APA

VCBacked. (2025). CytoVale — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/cytovale

Wikipedia (cite web)

{{cite web |title=CytoVale — Funding & Investors |url=https://www.vcbacked.co/company/cytovale |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 15, 2025.